Not a test of Thymalin alone · 1997
Natural and synthetic thymic peptides as therapeutics for immune dysfunction.
Morozov et al. 1997International journal of immunopharmacologycited by 37
PMID 9637345DOI 10.1016/s0192-0561(97)00058-1PUB-09637345
PepBank has 161 Thymalin studies with results. 85 of them gave Thymalin, with 242 results, grouped by what the studies measured. In each group, results from studies in people come first. Data as of 2026-10-30.
Searches 242 results and 259 papers. Newer studies from Europe PMC
Identifiers, parent molecule, targets and development stage, from curated data.
Thymalin is a thymus-extract medicine. Samson-Med identifies its active substance as thymus extract and lists Russian registration ЛС-000267. This mixture is not the separate peptide nonathymulin returned by the PubChem name search. The record does not assign a single sequence or receptor target.
No molecular target is recorded for this peptide.
Residues, differences from the parent, calculated properties and 3D structure. Source values and calculated values are shown separately.
Sequence not disclosed
The manufacturer identifies the active substance as thymus extract. It does not supply a single defined sequence or chemical structure. PubChem maps the name thymalin to nonathymulin, CID 3085284. That discrete peptide does not identify this extract.
No formula or molecular weight is listed for Thymalin.
No sequence is listed, so nothing can be calculated.
No charge curve
No sequence is listed for this peptide.
No sequence is listed for this peptide.
No 3D structure
No experimental structure (PDB) and no UniProt entry for an AlphaFold model are listed for this peptide. Synthetic peptides often have neither. The sequence view above is the reference.
People first in each area, then animals, then lab cells. Counts are exact and come from studies that gave the peptide.
PepBank reads each paper before it shows the results. This search looks in Europe PMC for newer papers that PepBank has not read yet.
Counts are exact and come from studies that gave the peptide.
Studies by year
161 of 259 studies have results (62%), published 1981 to 2024. Top row: every study. Bottom row: studies with results about Thymalin, by class. The rows use different scales.
Studies259 in all, 1981 to 2024
Studies with results161 in all, 1981 to 2024
Retracted studies are left out. A study with results in two classes counts in both.
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
Registered trials that test the peptide, with phase, status and dates. A dot marks trials with posted results.
0 trials match. Highest phase first. Data from ClinicalTrials.gov.
No trial matches these filters.
Studies on this peptide. Some have results. The others have none yet.
259 studies match. Retracted studies are left out.
Showing 19 of 259 studiesquery qry_7fa4f47fedf44b5151a678d9
161 studies in all, 15 on this page
Not a test of Thymalin alone · 1997
Morozov et al. 1997International journal of immunopharmacologycited by 37
PMID 9637345DOI 10.1016/s0192-0561(97)00058-1PUB-09637345
Measured the body's own Thymalin · 2000
Khlystova et al. 2000Bulletin of experimental biology and medicinecited by 6
PMID 11177305DOI 10.1023/a:1002882327810PUB-11177305
Non-randomized trial · 2003
VKh et al. 2003Neuro endocrinology letterscited by 6
PMID 14523363PUB-14523363
Animal study (in vivo) · cba mice and broiler chickens · 1998
Belokrylov et al. 1998Drug development and industrial pharmacycited by 5
PMID 15605441DOI 10.3109/03639049809085596PUB-15605441
Animal study (in vivo) · mouse · 1989
Hermánek et al. 1989Folia parasitologicacited by 4
PMID 2488049PUB-02488049
Animal study (in vivo) · rat · 2018
Zhukova et al. 2018Bulletin of experimental biology and medicinecited by 4
PMID 29797130DOI 10.1007/s10517-018-4104-zPUB-29797130
Not a test of Thymalin alone · 1991
Demidov et al. 1991Problemy tuberkulezacited by 3
PMID 1803376PUB-01803376
Measured the body's own Thymalin · 2003
Khlystova et al. 2003Bulletin of experimental biology and medicinecited by 3
PMID 12937685DOI 10.1023/a:1025449923475PUB-12937685
In vitro (cells) · 2020
Khavinson et al. 2020Bulletin of experimental biology and medicinecited by 3
PMID 33237528PMC7686446DOI 10.1007/s10517-020-05016-zPUB-33237528
Animal study (in vivo) · mouse · 1989
Baumgart et al. 1989Neoplasmacited by 2
PMID 2770926PUB-02770926
Not a test of Thymalin alone · 1994
Ivanova et al. 1994Problemy tuberkulezacited by 2
PMID 7937662PUB-07937662
Non-randomized trial · 2021
Khavinson et al. 2021Stem cell reviews and reportscited by 2
PMID 33575961PMC7877506DOI 10.1007/s12015-020-10087-6PUB-33575961
Animal study (in vivo) · mouse · 1991
Baumgart et al. 1991Archivum immunologiae et therapiae experimentaliscited by 1
PMID 1841547PUB-01841547
Animal study (in vivo) · rat · 1988
Bespalov et al. 1988Voprosy onkologiicited by 1
PMID 3341127PUB-03341127
Animal study (in vivo) · rat · 1987
Vilkov et al. 1987Biulleten' eksperimental'noi biologii i meditsinycited by 1
PMID 3663910DOI 10.1007/bf00841993PUB-03663910
66 studies in all, 4 on this page
PubMed tag: Review · 2010
Lin'kova et al. 2010Advances in gerontology = Uspekhi gerontologiicited by 5
PMID 21510076DOI 10.1134/s2079057011030076PUB-21510076
PubMed tag: Review · 2013
VKh et al. 2013Advances in gerontology = Uspekhi gerontologiicited by 5
PMID 24003726PUB-24003726
PubMed tag: Review · 2011
Lin'kova et al. 2011Advances in gerontology = Uspekhi gerontologiicited by 2
PMID 21809618PUB-21809618
PubMed tag: Comparative Study · 1987
Trekova et al. 1987Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlovacited by 1
PMID 3433946PUB-03433946
These studies name Thymalin but give no result for it (for example, the results concern another peptide in the study).
Indexing hint: Animal study · 2000
Anisimov et al. 2000Biogerontologycited by 18
PMID 11707921DOI 10.1023/a:1010042008969PUB-11707921
PubMed tag: none · 2022
Avolio et al. 2022International journal of molecular sciencescited by 15
PMID 35408963PMC8999041DOI 10.3390/ijms23073607PUB-35408963
PubMed tag: Review · 2002
VKh et al. 2002Neuro endocrinology letterscited by 14
PMID 12374906PUB-12374906
PubMed tag: Comparative Study · 1991
Mal'khanov et al. 1991Vestnik oftalmologiicited by 2
PMID 1763455PUB-01763455
Indexing hint: Animal study · 2004
IuIa et al. 2004Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994)cited by 2
PMID 15320428PUB-15320428
PubMed tag: Comparative Study · 1989
Bespalov et al. 1989Eksperimental'naia onkologiiacited by 1
PMID 2759010PUB-02759010
Page 1 of 4
Ivanova LA · Vrachebnoe delo · 1989
Non-randomized trial · 2 results
Gol'zand IV · Zhurnal mikrobiologii, epidemiologii i immunobiologii · 1986
Non-randomized trial · 6 results
Vishnevskaia EE · Voprosy onkologii · 1991
Non-randomized trial · 2 results
Trishina SV · Likars'ka sprava · 1995
Non-randomized trial · 1 result
Tkach SM · Likars'ka sprava · 1992
Non-randomized trial · 1 result
Dekster LI · Voprosy onkologii · 1984
Non-randomized trial · 1 result
Kazantseva IA · Stomatologiia · 1994
Non-randomized trial · 2 results
Dovnar TE · Terapevticheskii arkhiv · 1989
Non-randomized trial · 8 results
Kuznik BI · Farmakologiia i toksikologiia · 1984
Non-randomized trial · 6 results
Musienko GV · Likars'ka sprava · 1999
Non-randomized trial · 4 results
Khavinson VKh · Neuro endocrinology letters · 2003
Non-randomized trial · 9 results
Khavinson VK · Stem cell reviews and reports · 2021
Non-randomized trial · 1 result
Kuznik BI · Advances in gerontology = Uspekhi gerontologii · 2022
Non-randomized trial · 11 results
Tsybikov MN · Khirurgiia · 2012
Non-randomized trial · 3 results
Talyshinskiĭ AM · Vestnik otorinolaringologii · 2001
Non-randomized trial · 4 results
Midlenko AI · Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko · 2000
Non-randomized trial · 1 result
Siurin SA · Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury · 1997
Non-randomized trial · 1 result
Shkrob LO · Khirurgiia · 1990
Non-randomized trial · 2 results
Perederiĭ VG · Sovetskaia meditsina · 1990
Non-randomized trial · 4 results
Khmel'nitskaia NM · Arkhiv patologii · 1990
Non-randomized trial · 4 results
Gol'zand IV · Terapevticheskii arkhiv · 1989
Non-randomized trial · 1 result
Mats AN · Zhurnal mikrobiologii, epidemiologii i immunobiologii · 1987
Non-randomized trial · 2 results
Kuznik BI · Terapevticheskii arkhiv · 1986
Non-randomized trial · 8 results
Golovkin VI · Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952) · 1984
Non-randomized trial · 1 result
Kuznik BI · Vestnik khirurgii imeni I. I. Grekova · 2000
Case report or series · 6 results
Khavinson VKh · Voprosy meditsinskoi khimii · 1990
Other design · 5 results
Chukhlovina ML · Zhurnal mikrobiologii, epidemiologii i immunobiologii · 1994
Animal study (in vivo) · mouse · 1 result
Belokrylov GA · Drug development and industrial pharmacy · 1998
Animal study (in vivo) · cba mice and broiler chickens · 3 results
Zhukova GV · Bulletin of experimental biology and medicine · 2018
Animal study (in vivo) · rat · 6 results
Hermánek J · Folia parasitologica · 1989
Animal study (in vivo) · mouse · 4 results
Baumgart J · Neoplasma · 1989
Animal study (in vivo) · mouse · 1 result
Labunets' IF · Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) · 2005
Animal study (in vivo) · cba mice · 2 results
Labunets' IF · Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) · 2001
Animal study (in vivo) · 2 results
Baumgart J · Archivum immunologiae et therapiae experimentalis · 1991
Animal study (in vivo) · mouse · 1 result
Bespalov VG · Voprosy onkologii · 1988
Animal study (in vivo) · rat · 1 result
Vilkov GA · Biulleten' eksperimental'noi biologii i meditsiny · 1987
Animal study (in vivo) · rat · 2 results
Kovalev S · Journal of animal science · 2019
Animal study (in vivo) · cattle · 6 results
Kuznetsova TA · Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] · 2013
Animal study (in vivo) · 6 results
Labunets IF · Advances in gerontology = Uspekhi gerontologii · 2011
Animal study (in vivo) · cba mice · 6 results
Kozak MV · Advances in gerontology = Uspekhi gerontologii · 2009
Animal study (in vivo) · rat · 1 result
Labunets IF · Advances in gerontology = Uspekhi gerontologii · 2007
Animal study (in vivo) · cba mice · 7 results
Labunets' IF · Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) · 2006
Animal study (in vivo) · cba mice · 4 results
Platonov IA · Eksperimental'naia i klinicheskaia farmakologiia · 2004
Animal study (in vivo) · rat · 3 results
Musaev MU · Likars'ka sprava · 2001
Animal study (in vivo) · 2 results
Kasymova GG · Morfologiia (Saint Petersburg, Russia) · 2001
Animal study (in vivo) · 4 results
Pylaeva SI · Zhurnal mikrobiologii, epidemiologii i immunobiologii · 2000
Animal study (in vivo) · 5 results
Grechko AT · Eksperimental'naia i klinicheskaia farmakologiia · 1998
Animal study (in vivo) · 15 results
Lukash NV · Likars'ka sprava · 1995
Animal study (in vivo) · wistar male rats · 2 results
Sukhodoeva GS · Zhurnal mikrobiologii, epidemiologii i immunobiologii · 1993
Animal study (in vivo) · guinea pig · 6 results
Khavinson VKh · Zhurnal mikrobiologii, epidemiologii i immunobiologii · 1993
Animal study (in vivo) · mouse · 11 results
Approval and sport status, and the safety outcomes reported in study results. Laws and labels change, so check the regulator for the current status.
| Jurisdiction | Body | Status | As of | Source |
|---|---|---|---|---|
| US | FDA | Drugs@FDA searches for thymalin, thymaline and timalin returned no brand or active ingredient matches. This is a name-based negative search. | 22 Oct 2026 | api.fda.gov (opens in a new tab) |
| EU | EMA | No matching active substance in the EMA central medicines data file. National authorisations are not covered. | 22 Oct 2026 | ema.europa.eu (opens in a new tab) |
| Sport | WADA | Not listed as banned by WADA No thymalin, thymaline or timalin name appears in the official list webpage linked to WADA 2026. | 2026 List | wada-ama.org (opens in a new tab) |
| Russia | National register | Approved in Russia Registered medicine Thymalin (Тималин), holder Samson-Med: registration ЛС-000267 of 2010-02-26, valid to 2027-12-18. Read from a copy of the State Register of Medicines (pharmcontrol.ru, register data of 2026-10-02); the official register search was not read. | 22 Oct 2026 | pharmcontrol.ru (opens in a new tab) |
4 safety results for Thymalin.
In elderly and older people, mortality in the Thymalin-treated group was 2.0-2.1-fold lower than control during observation.
Non-randomized trialn not reported
In middle-aged and elderly patients with severe COVID-19, hospital mortality was 20.6% with Thymalin versus 40.9% with basic therapy.
Non-randomized trialn not reported
In middle-aged and elderly patients with severe COVID-19, hospital mortality was 20.6% with Thymalin versus 28.4% with Tocilizumab.
Non-randomized trialn not reported
In immunized guinea pigs, the study established the possibility of allergic reactions to thymalin.
Animal study (in vivo)guinea pig
The doses that these studies used. They are not recommendations.
5 ml, 4-6 injections per treatment courseHuman
100 micrograms per mouseAnimal
1.2 mg/kgAnimal
0.66 mg/kgAnimal
0.2 mlg/miceAnimal
1 mg/kg/dayAnimal
6 of 10 shown
PepBank is a research reference. Talk to a doctor before you use any peptide.
Data version, change history and code for this peptide.
curl -s https:// pepbank.io/ v1/ briefs/ thymalinEvidence summary for Thymalin: counts by class, key results with sources, notices, data version.
In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated
Top outcomes
The 8 outcome groups with the most study results, by evidence class.
Data version 308560. Bar length is the number of results, not the size of an effect.
Evidence matrix
Study results by outcome and evidence class. Arrows show how the measured outcome moved, not whether the change is good.
| Outcome group | Human | Animal | Lab | Computer model | Total |
|---|---|---|---|---|---|
| Immune responseWhole body | Human: 40 results from 17 studies: 13 increase, 4 decrease, 8 no significant change, 15 not reported. Strongest design: Non-randomized trial | Animal: 56 results from 26 studies: 28 increase, 4 decrease, 9 no significant change, 1 mixed, 14 not reported. Strongest design: Animal study (in vivo) | Lab: 11 results from 5 studies: 6 increase, 2 decrease, 3 not reported. Strongest design: Ex vivo tissue | No results | 107 |
| Bleeding and clottingCardiovascular | Human: 9 results from 4 studies: 1 increase, 4 decrease, 4 not reported. Strongest design: Non-randomized trial | Animal: 11 results from 4 studies: 2 increase, 2 decrease, 1 no significant change, 6 not reported. Strongest design: Animal study (in vivo) | Lab: 2 results from 1 study: 1 increase, 1 no significant change. Strongest design: In vitro (cell-free) | No results | 22 |
| Inflammation markersImmune and inflammation | Human: 5 results from 4 studies: 1 increase, 2 decrease, 2 not reported. Strongest design: Non-randomized trial | Animal: 1 result from 1 study: 1 not reported. Strongest design: Animal study (in vivo) | Lab: 3 results from 1 study: 3 increase. Strongest design: In vitro (cells) | No results | 9 |
| MortalityWhole body | Human: 3 results from 2 studies: 3 decrease. Strongest design: Non-randomized trial | Animal: 5 results from 3 studies: 3 increase, 1 decrease, 1 no significant change. Strongest design: Animal study (in vivo) | No results | No results | 8 |
| Infection and antimicrobial activityRespiratory | Human: 3 results from 2 studies: 1 increase, 1 no significant change, 1 not reported. Strongest design: Non-randomized trial | Animal: 4 results from 4 studies: 4 decrease. Strongest design: Animal study (in vivo) | No results | No results | 7 |
| Receptor activity and mechanismWhole body | Human: 2 results from 1 study: 2 not reported. Strongest design: Other design | Animal: 21 results from 11 studies: 4 increase, 4 decrease, 2 no significant change, 4 mixed, 7 not reported. Strongest design: Animal study (in vivo) | Lab: 2 results from 1 study: 2 increase. Strongest design: Ex vivo tissue | No results | 25 |
| Cancer treatment responseCancer | Human: 2 results from 1 study: 2 increase. Strongest design: Non-randomized trial | No results | No results | No results | 2 |
| Wound healingSkin and wound | Human: 2 results from 2 studies: 1 increase, 1 decrease. Strongest design: Non-randomized trial | No results | No results | No results | 2 |
| Gastrointestinal protectionGastrointestinal | Human: 1 result from 1 study: 1 decrease. Strongest design: Non-randomized trial | Animal: 2 results from 1 study: 2 decrease. Strongest design: Animal study (in vivo) | No results | No results | 3 |
| Exercise and physical functionWhole body | Human: 1 result from 1 study: 1 decrease. Strongest design: Non-randomized trial | Animal: 1 result from 1 study: 1 decrease. Strongest design: Other design | No results | No results | 2 |
| Overall treatment effectWhole body | Human: 1 result from 1 study: 1 increase. Strongest design: Non-randomized trial | Animal: 1 result from 1 study: 1 not reported. Strongest design: Animal study (in vivo) | No results | No results | 2 |
| Aging markersNervous system and cognition | Human: 1 result from 1 study: 1 not reported. Strongest design: Non-randomized trial | No results | No results | No results | 1 |
12 outcome groups shown of 31 · 242 study results
Data version 308560. Shade grows with the number of results. Every cell shows the exact count.
Results that measure endogenous levels of Thymalin. The peptide was not administered. The matrix does not count them.
| Outcome group | Human | Animal | Lab | Computer model | All |
|---|---|---|---|---|---|
| Receptor activity and mechanismWhole body | 2 | – | 9 | – | 11 |
| Immune responseImmune and inflammation | 2 | – | 3 | – | 5 |
| Aging markersWhole body | – | – | 4 | – | 4 |
| All outcome groups | 4 | – | 16 | – | 20 |